ONO-2952
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for ONO-2952, covering 2012-06-13 to 2016-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) [Phase 2]